CD4 and Miyoshi myopathy: On the one hand, MM-MSCs revealed deficiency in osteogenic differentiation potential and cellular vitality, decline in suppressing CD4+ T lymphocytes and increase in promoting Th17 cells compared with HD-MSCs, whereas no differences in immunophenotypes, adipogenic and chondrogenic differentiation, pluripotency-related biomarker expression, chromosome karyotype.